Compare ROIV & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | CFLT |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 7.7B |
| IPO Year | N/A | 2021 |
| Metric | ROIV | CFLT |
|---|---|---|
| Price | $22.56 | $29.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 32 |
| Target Price | $24.31 | ★ $29.93 |
| AVG Volume (30 Days) | 8.2M | ★ 19.6M |
| Earning Date | 02-09-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,329,000.00 | ★ $1,113,149,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | $376.94 | $16.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.57 |
| 52 Week Low | $8.73 | $15.64 |
| 52 Week High | $23.47 | $37.90 |
| Indicator | ROIV | CFLT |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 77.28 |
| Support Level | $21.60 | $29.96 |
| Resistance Level | $23.47 | $30.07 |
| Average True Range (ATR) | 0.88 | 0.32 |
| MACD | 0.06 | 0.34 |
| Stochastic Oscillator | 69.09 | 96.74 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.